Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy-Reference-Cited by-同舟云学术

Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy

Published:2014-10-27 Issue:2 Volume:47 Page:251-258
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Oh Dongryul,Shin Sung Wook,Park Hee Chul,Cho Sung Ki,Lim Do Hoon,Paik Seung Woon

Funder

National Research Foundation of Korea

Samsung Medical Center

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2014-011.pdf

Reference22 articles.

1. INCIDENCE, RISK FACTORS, MANAGEMENT, AND OUTCOME OF PORTAL VEIN ABNORMALITIES AT ORTHOTOPIC LIVER TRANSPLANTATION

2. Multidisciplinary Management of Nonresectable Hepatocellular Carcinoma

3. Angiographic Demonstration of Intrahepatic Arterio-Portal Anastomoses in Hepatocellular Carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization;Journal of Cancer Research and Clinical Oncology;2022-07-05

2. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt;Abdominal Radiology;2021-07-24

3. Multidisciplinary treatment of advanced hepatocellular carcinoma with severe arterioportal shunt: a case report;Journal of International Medical Research;2021-07

4. Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma;Scientific Reports;2021-05-17

5. Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS;European Radiology;2021-04-24